An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?-Reference-Cited by-同舟云学术

An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?

Published:2017-12-04 Issue:1 Volume:18 Page:5-12
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Hertzman Peter¹,Miller Paul²,Tolley Keith³

Affiliation:

1. Health Access Agency GmbH, Zurich, Switzerland

2. Miller Economics Ltd

3. Tolley Health Economics, Buxton, Derbyshire, UK

Funder

Health Access Agency, Miller Economics Ltd and Tolley Health Economics

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2018.1411192

Reference44 articles.

1. Garrison. Performance-based risk sharing arrangement: ISPOR good practice. 2013. [Cited Feb 2017]. Available from: http://www.ispor.org/TaskForces/documents/Performance-based-Risk-Sharing-Guidelines.pdf

2. Technology Assessment for New Oncology Drugs

3. Cancer Drugs in the United States: Justum Pretium—The Just Price

4. How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. General Population Mortality Adjustment in Survival Extrapolation of Cancer Trials: Exploring Plausibility and Implications for Cost-Effectiveness Analyses in HER2-Positive Breast Cancer in Sweden;Medical Decision Making;2024-09-12

2. Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis;International Journal of Environmental Research and Public Health;2020-11-10

3. Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices;JAMA Oncology;2020-06-01

4. Dance Nation and Its Representational Challenges;Modern Drama;2020-05

5. The Price of Substitute Technologies;Value in Health Regional Issues;2019-12